Corporate Banner
Satellite Banner
Informatics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Accelrys and eMolecules Collaborate to Enhance Accelrys Available Chemicals Directory

Published: Saturday, April 06, 2013
Last Updated: Saturday, April 06, 2013
Bookmark and Share
Validated and curated in-stock compounds from eMolecules now accessible through Accelrys ACD

Accelrys, Inc., a leading provider of scientific innovation lifecycle management software, and eMolecules, Inc, a market-leading compound sourcing platform, announced that they are collaborating to include eMolecules' in-stock building block compounds in the Accelrys Available Chemicals Directory (ACD) database.  Adding eMolecules into Accelrys ACD enables scientists to identify the optimal set of compounds for their synthesis or library with increased confidence that those compounds will be available at the indicated prices from the selected suppliers.

"Now, with the inclusion of validated and curated compound availability information from eMolecules, Accelrys ACD customers can order with increased confidence that chemical suppliers will deliver the compounds on time," said Dr. Matt Hahn , senior vice president and chief technology officer, Accelrys.  "Together, Accelrys and eMolecules are revolutionizing the efficiency and reliability of compound acquisition throughout our shared markets."

"This collaboration will help Accelrys ACD users acquire the in-stock compounds critical to their projects' progress in an efficient and easy way," said Niko Gubernator , CEO of eMolecules.  "eMolecules is excited to demonstrate to Accelrys' ACD users how our revolutionary approach to compound purchasing has delivered industry-proven results in improving efficiencies, lowering costs and driving innovation for pharmaceutical, biotech and academic groups alike."

The eMolecules online chemical compound sourcing platform has rapidly established itself as a market leader in enabling scientists to source and purchase commercially available 'in-stock' compounds reliably and efficiently.  Accelrys ACD, used and trusted for more than 25 years by researchers in the global pharmaceutical, biotechnology, chemical and agrochemical sectors, enables scientists to access high quality curated and harmonized chemical property, availability and pricing information on 7.8 million compounds from 940 suppliers, with the information available via numerous delivery mechanisms including remotely hosted services.

As a result of the collaboration between Accelrys and eMolecules, ACD compounds now include more than 580,000 in-stock building blocks from more than 200 trusted eMolecules suppliers. With the inclusion of the unique eMolecules compound identifiers in ACD, and the equivalent unique ACD identifiers in the eMolecules catalog, ACD users can now prepare their order list using ACD and then quickly, easily and confidently order their compounds from multiple suppliers using the eMolecules fulfillment service. The eMolecules platform enables scientists to obtain real-time information on ready-to-be-shipped compounds and access online management tools for tracking orders and determining delivery times.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

ALMA Welcomes Accelrys as a Premium Sponsor
Association of Lab Managers (ALMA) now supported by leading lab software provider Accelrys
Friday, April 04, 2014
Dassault Systèmes and Accelrys to Join Forces
Delivering Scientific Innovation in the Age of Experience
Friday, January 31, 2014
Accelrys Acquires QUMAS
The acquisition extends Accelrys’ informatics portfolio with the addition of mission-critical, end-to-end document and process management compliance solutions.
Tuesday, December 10, 2013
Accelrys Receives Highest Rating in Gartner's Latest Laboratory Informatics System Report
Accelrys was the only vendor to achieve the highest possible rating in all five categories of new product development (NPD)
Friday, October 11, 2013
Cambridge Isotope Laboratories Selects Accelrys Lab Automation Software
Cambridge Isotope Laboratories, Inc. is deploying the Accelrys Laboratory Execution System (LES) and three applications within the Accelrys Laboratory Information Management System.
Tuesday, September 10, 2013
Accelrys Acquires Environmental Health and Safety Leader ChemSW
Chemical inventory management solutions improve compliance and sustainability impact of Accelrys’ Scientific Innovation Lifecycle Management portfolio
Wednesday, September 04, 2013
Cambridge Isotope Laboratories Selects Accelrys Lab Automation Software
Enterprise implementation follows successful pilot that achieved a 78 percent reduction in data review times and a 40 percent overall improvement in lab processing time
Sunday, September 01, 2013
The Evolution of the Integrated Platform: Accelrys' One-Two Punch
A look at how Accelrys is delivering an integrated platform of enterprise laboratory solutions.
Sunday, June 02, 2013
Accelrys' Electronic Laboratory Notebooks Recognized in Gartner's Enterprise Category
Accelrys' electronic laboratory notebooks (ELN) as "very high" or "high" in each scientific and functional domain in a recent report by Gartner, Inc.
Sunday, March 03, 2013
Accelrys® ELN Delivers Seamless Integration with the Reaxys® Workflow Solution
New chemistry information management possibilities for research scientists arising from Accelrys' cooperation with Elsevier.
Sunday, March 03, 2013
Accelrys, Inc. Acquires Vialis AG
Accelrys Strengthens Leadership Position in Laboratory Informatics Market
Sunday, February 10, 2013
Accelrys Acquires Systems Integrator Vialis
Accelrys has acquired Vialis AG to solidify its market leadership in the laboratory informatics space
Sunday, January 20, 2013
German Cancer Research Center Selects Contur ELN from Accelrys
The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) has licensed the server-based, on-premises version of Accelrys' Contur Electronic Lab Notebook (ELN).
Friday, December 28, 2012
Aquavit Pharmaceuticals forms Alliance Partnership with Accelrys
Aquavit to utilize Accelrys Enterprise Platform to develop advanced medical software
Sunday, November 11, 2012
Accelrys Acquires Aegis Analytical Corp. for $30 million in cash
New enterprise manufacturing process intelligence software capabilities expand Accelrys' footprint in downstream product development and commercialization operations
Sunday, November 11, 2012
Scientific News
Improving Crop Efficiency with CRISPR
New study of CRISPR-Cas9 technology from Virginia Tech shows potential to improve crop efficiency.
Gene Therapy Technique May Help Prevent Cancer Metastasis
Gene-regulating RNA molecules could help treat early-stage breast cancer tumors before they spread.
Space Research Fighting Cancer
JPL and National Cancer Institute renew Big Data partnership that 'learns' data similarities.
First Accurate Simulation of a Virus Invading a Cell
For the first time, scientists know what happens to a virus’ shape when it invades a host cell.Understanding how the virus shape specifically changes could lead to more effective anti-viral therapies.
Manipulation of Liquid Crystals Could Help Control Drug-Delivery Process
Computer modeling, real-world testing yields new method.
A New Approach for Deciphering Complex Immune Responses
Study seeks to establish the parameters that characterize the immune system of healthy individuals and its natural variability.
Infectious Prion Structure Shines Light on BSE
Prion research useing electron cryomicroscopy technology identified the structure of the infectious prion protein that causes BSE.
Vaccination Strategies Coax HIV-Neutralizing Antibody Production
New approaches to encourage the human immune system to produce HIV-blocking antibodies have been successful in mice.
Sequencing Soviet Anthrax
Next-gen genomic analysis has generated an anthrax genome sequence formerly from the USSR’s biological weapons program.
Closer to ‘Flesh-Eating’ Bacteria Vaccine
Patterns uncovered in the outer protein coat of group A Strep could lead to a vaccine againt the bacteria.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!